Asia Pacific Contract Research Organization (CRO) Market to 2025 - Regional Analysis and Forecast by Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, Post-Approval Services); End User (Pharmaceutical & Biotechnology Companies and Medical Device Companies), and Country
- THE3479227
- 149 Pages
- January 2020
- Pharmaceuticals
The growth of the market is driven by factors such as the rise in the number of clinical trials. On the other hand, the shortage of skilled professionals in some of the APAC countries is limiting the growth of the market is likely to have a negative impact on the market growth in the coming years.
The CRO industry is uneven, with several small and medium-sized service providers are operating in the global CRO market. There are barriers to the entry of smaller CROs into the global market whereas a full-service CRO with global capabilities requires building the necessary infrastructure with the ability to simultaneously manage multiple complex testing services across numerous geographies. They have established requisite relationships with strategic partners, developing relevant therapeutic and development of expertise to serve the needs of the end-users.
Over the past years, the consolidation in the CRO industry is emerging. It is followed by the majority of the prime players to strengthen their service offerings and gain a significant market share in the regional CRO market. Thus it has led to the availability handful of larger CROs with broad geographic diversification, extensive therapeutic and development expertise, enormous capital, and technical resources to manage the demanding drug development programs of pharmaceutical and biopharmaceutical companies. CRO's service market is creating various opportunities that are leading to the growth of the market and industries. The current going trend in the CRO industry is for the consolidation of the market. Various large players have signed agreements, some of them have merged and acquired different companies. Some of the instances are below.
The secondary sources used for validations and data mining in the Europe contract research organization market includes Pharmaceuticals and Medical Devices Agency (PMDA), Food and Drug Administration (FDA), European Federation of Pharmaceuticals Industries Associations (EFPIA), World Health Organization (WHO), are among the others.
1. Introduction
1.1 Scope Of The Study
1.2 The Insight ners Research Report Guidance
2. APAC Contract Research Organization (CRO) Market – Key Takeaways
3. APAC Contract Research Organization (CRO) Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 APAC Contract Research Organization (CRO) Market – By Type
3.2.2 APAC Contract Research Organization (CRO) Market – By End User
3.2.3 APAC Contract Research Organization (CRO) Market – By Country
4. APAC Contract Research Organization (CRO) Market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Involvement of Government in R&D Activities
4.1.2 Rise In The Number Of Clinical Trials
4.2 Key Market Restraints
4.2.1 Dearth Of Skilled Professionals
4.2.2 Competition In The Cro Services Market
4.3 Key Market Opportunities
4.3.1 Growing Biosimilars And Biologics Market
4.3.2 Increasing Demand For Specialized Testing Services
4.4 Future Trends
4.4.1 Increasing Market Consolidation
4.5 Impact Analysis
5. Contract Research Organization (CRO) Market – APAC Analysis
5.1 APAC Contract Research Organization (CRO) Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
5.4 Expert Opinions
6. APAC Contract Research Organization (CRO) Market Analysis – By Type
6.1 Overview
6.2 APAC Contract Research Organization (CRO) Market, By Type 2017 & 2025 (%)
6.3 APAC Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By Type (Us$ Mn)
6.4 Early Phase Development Services Market
6.4.1 Overview
6.4.2 APAC Early Phase Development Services Market Revenue And Forecasts To 2025 (Us$ Mn)
6.4.3 Drug Discovery Services
6.4.3.1 Overview
6.4.3.2 APAC Drug Discovery Services Market Revenue And Forecasts To 2025 (Us$ Mn)
6.4.4 Pre-Clinical Services
6.4.4.1 Overview
6.4.4.2 APAC Pre-Clinical Services Market Revenue And Forecasts To 2025 (Us$ Mn)
6.5 Clinical Research Services
6.5.1 Overview
6.5.2 APAC Clinical Research Services Market Revenue And Forecasts To 2025 (Us$ Mn)
6.6 Laboratory Services
6.6.1 Overview
6.6.2 APAC Laboratory Services Market Revenue And Forecasts To 2025 (Us$ Mn)
6.7 Post-Approval Services
6.7.1 Overview
6.7.2 APAC Post-Approval Services Market Revenue And Forecasts To 2025 (Us$ Mn)
7. APAC Contract Research Organization (CRO) Market Analysis – By End User
7.1 Overview
7.2 APAC Contract Research Organization (CRO) Market, By End User, 2017 & 2025 (%)
7.3 APAC Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By End User (Us$ Mn)
7.4 Pharmaceutical And Biotechnology Companies
7.4.1 Overview
7.4.2 APAC Pharmaceutical And Biotechnology Companies Market Revenue And Forecasts To 2025 (Us$ Mn)
7.5 Medical Device Companies
7.5.1 Overview
8. APAC Contract Research Organization (CRO) Market Revenue And Forecasts To 2025
8.1 Overview
8.2 Asia Pacific Contract Research Organization (CRO) Market Revenue And Forecasts To 2025 (Us$ Mn)
8.3 Asia Pacific Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By Type (Us$ Mn)
8.3.1 Asia Pacific Early Phase Development Services Market Revenue And Forecasts To 2025, By Type (Us$ Mn)
8.4 Asia Pacific Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By End User (Us$ Mn)
8.5 Asia Pacific Contract Research Organization (CRO) Market Share, By Country (2017 & 2025) (%)
8.6 China Contract Research Organization (CRO) Market Revenue And Forecasts To 2025 (Us$ Mn)
8.6.1 China Contract Research Organization (CRO) Market Revenue And Forecasts To 2025 (Us$ Mn)
8.6.2 China Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By Type (Us$ Mn)
8.6.2.1 China Early Phase Development Services Market Revenue And Forecasts To 2025, By Type (Us$ Mn)
8.6.3 China Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By End User (Us$ Mn)
8.7 Japan Contract Research Organization (CRO) Market Revenue And Forecasts To 2025 (Us$ Mn)
8.7.1 Japan Contract Research Organization (CRO) Market Revenue And Forecasts To 2025 (Us$ Mn)
8.7.2 China Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By Type (Us$ Mn)
8.7.2.1 Japan Early Phase Services Market Revenue And Forecasts To 2025, By Type (Us$ Mn)
8.7.3 Japan Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By End User (Us$ Mn)
8.8 India Contract Research Organization (CRO) Market Revenue And Forecasts To 2025 (Us$ Mn)
8.8.1 India Contract Research Organization (CRO) Market Revenue And Forecasts To 2025 (Us$ Mn)
8.8.2 India Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By Type (Us$ Mn)
8.8.2.1 India Early Phase Development Services Market Revenue And Forecasts To 2025, By Type (Us$ Mn)
8.8.3 India Contract Research Organization (CRO) Market Revenue And Forecasts To 2025, By End User (Us$ Mn)
9. Contract Research Organization (CRO) Market –Industry Landscape
9.1 Overview
9.2 Growth Strategies In The Contract Research Organization (CRO) Market, 2015-2018
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.3.2 Merger & Acquisitions
9.3.3 Collaborations
9.3.4 nership
9.3.5 Alliance
9.3.6 Agreement & Joint Venture
9.4 Organic Growth Strategies
9.4.1 Overview
9.4.2 Launch
9.4.3 Expansion & Relocation
9.4.4 Enhancements
10. CONTRACT RESEARCH ORGANIZATION (CRO) MARKET – KEY COMPANY PROFILES
10.1 IQVIA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Information
10.1.4 Service Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Parexel International Corporation
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Service Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 SYNEOS Health
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Information
10.3.4 Service Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Laboratory Corporation of America Holdings
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Service Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 PRA Health Sciences, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Overview
10.5.4 Service Portfolio
10.5.5 Swot Analysis
10.5.6 Key Developments
10.6 Charles River
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Service Portfolio
10.6.5 Swot Analysis
10.6.6 Key Developments
10.7 ICON plc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Service Portfolio
10.7.5 Swot Analysis
10.7.6 Key Developments
10.8 Pharmaceutical Product Development, llc.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Service Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 WUXI APPTEC
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Service Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 MEDPACE
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Service Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. APPENDIX
11.1 About The Insight ners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
